Legion Health, a YC startup, became the world's first company with regulatory approval to prescribe psychiatric medications via AI. It operates under Utah's AI regulatory sandbox — the same framework another startup, Doctronic, has used since January to renew 190 common medications for $4/month.
The Legion bot renews prescriptions for SSRIs (Zoloft, Lexapro), Wellbutrin, trazodone, and mirtazapine. These are standard maintenance treatments for depression and anxiety. The first prescription is written by a human psychiatrist; the bot only handles renewals. Adderall, painkillers, and all controlled substances are excluded.
The rollout is gradual: the first 250 prescriptions with physician oversight, the next 1,000 with post-review, and after that — autonomously. Subscription is $20/month (free with insurance).
At first I couldn't figure out the point (we're used to getting a prescription just by messaging your doctor on Telegram). But in the US, the median wait to see a psychiatrist is 67 days. Up to half of patients stop taking their medication because the prescription ran out and the next appointment is two months away. Someone on a stable dose of sertraline who just needs a refill — that's exactly the kind of task a bot handles just as well as a doctor who rubber-stamps the renewal in 3 minutes anyway.
Modern psychiatry around maintenance medications already runs like an assembly line. A psychiatrist sees a stable patient once every 3 months in a 15-minute slot, asks "how are you doing, any side effects?" and hits the "renew" button. AI does the same thing, just without the two-month wait.
WSJ reported it, The Verge covered it — and I'm covering their coverage: for now it's a one-state experiment, but Doctronic is already in talks with Texas, Arizona, and Missouri.